 | Relief Announces the Results of the Annual General Meeting 2021 of RELIEF THERAPEUTICS Holding AG: All Proposals Approved by a Large Majority
finance.yahoo.com - June 21 at 4:00 AM |
 | Relief Therapeutics Reports that Collaboration...
benzinga.com - June 18 at 12:54 AM |
| Relief Therapeutics Reports that Collaboration Partner, NRx Pharmaceuticals, has Announced Additional Results from the Aviptadil U.S. Expanded Access Protocol for Patients with Critical COVID-19
finance.yahoo.com - June 16 at 1:26 PM |
 | Relief Therapeutics Holding AG (OTCMKTS:RLFTF) Sees Significant Drop in Short Interest
americanbankingnews.com - June 14 at 11:44 AM |
| Relief Therapeutics (OTCMKTS:RLFTF) Stock Price Up 4.9%
americanbankingnews.com - June 5 at 12:36 AM |
| Relief Therapeutics Reports that its Collaboration Partner, NRx Pharmaceuticals, has Submitted an Application for Emergency Use Authorization for Aviptadil to the U.S. Food & Drug Administration
finance.yahoo.com - June 2 at 7:59 AM |
| NRx Pharmaceuticals Announces Positive Results for ZYESAMI™ (Aviptadil-acetate) and Submits Emergency Use Authorization Application to US Food and Drug Administration to Treat Critical COVID-19 in Patients Suffering from Respiratory Failure
finance.yahoo.com - June 1 at 8:22 AM |
 | Relief updates on progress of ACER-001 for urea cycle disorders
seekingalpha.com - May 19 at 5:24 PM |
|
 | Relief Therapeutics Holding AG: Relief Provides Update on Progress and Plans with ACER-001 for the Treatment of Urea Cycle Disorders
finanznachrichten.de - May 18 at 4:28 AM |
| Relief Provides Update on Progress and Plans with ACER-001 for the Treatment of Urea Cycle Disorders
finance.yahoo.com - May 18 at 4:28 AM |
| Relief Points to Applied Pharma Research (APR) News re: Pivotal COVID-19 Trial Initiation with Novel Nasal Spray
finance.yahoo.com - May 17 at 7:22 AM |
| Relief (RLFTF) inks binding term sheet to acquire outstanding shares of APR Applied Pharma
seekingalpha.com - May 5 at 2:02 PM |
| Relief and AdVita Announce Initiation of Phase 2 Trial with Inhaled RLF-100 for the Prevention of COVID-19-related Acute Respiratory Distress Syndrome
finance.yahoo.com - April 22 at 8:03 AM |
| Relief Therapeutics Holding AG: Relief Reports 2020 Financial Results and Provides Business Update
finanznachrichten.de - April 15 at 3:23 AM |
| Relief Reports 2020 Financial Results and Provides Business Update
finance.yahoo.com - April 15 at 3:23 AM |
 | NeuroRx takes another run at emergency use approval for experimental Covid-19 therapy
bizjournals.com - March 29 at 5:31 PM |
| NeuroRx Announces ZYESAMI™ (aviptadil, RLF-100)...
benzinga.com - March 29 at 7:24 AM |
| NeuroRx Announces ZYESAMI™ (aviptadil, RLF-100) Met the Primary Endpoint of Its Phase 2b/3 Clinical Trial and Also Demonstrated a Meaningful Benefit in Survival from Critical COVID-19
finance.yahoo.com - March 29 at 1:49 AM |
| Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease
finance.yahoo.com - March 22 at 8:59 AM |
| Relief Therapeutics Holding AG: Relief Reports that NeuroRx has Announced Feasibility Collaboration with TFF Pharmaceuticals
finanznachrichten.de - March 15 at 7:40 AM |
| Relief Reports that NeuroRx has Announced Feasibility Collaboration with TFF Pharmaceuticals
finance.yahoo.com - March 15 at 7:40 AM |
| Relief Therapeutics Holding AG: Relief Increases Issued Share Capital with Creation of Treasury Shares
finanznachrichten.de - March 8 at 7:54 AM |
|
| Relief Increases Issued Share Capital with Creation of Treasury Shares
finance.yahoo.com - March 8 at 7:54 AM |
| NeuroRx Announced that RLF-100(TM) has Demonstrated Ten-Day Accelerated Recovery from Respiratory Failure among Patients with Severe Covid-19 Treated with HFNO at 28 Day Interim Endpoint
finance.yahoo.com - February 24 at 7:46 AM |
 | Swiss-Based Biotech Pops On Covid-19 Related Results
baystreet.ca - February 23 at 3:13 PM |
| Relief Therapeutics' RLF-100 can reduce hospital stay due to COVID-19
seekingalpha.com - February 12 at 3:55 PM |
| Relief Confirms Release of Preliminary Findings from Phase 2b/3 Trial of Intravenous RLF-100(TM) (aviptadil)
finance.yahoo.com - February 10 at 10:12 AM |
| Relief Therapeutics Holding AG: Relief Announces Resignation of Thomaz Burckhardt as Member of the Board of Directors
finanznachrichten.de - February 9 at 8:33 AM |
| Relief Announces Resignation of Thomaz Burckhardt as Member of the Board of Directors
finance.yahoo.com - February 9 at 8:33 AM |
| NeuroRx and Relief Therapeutics Report Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™ in Reducing Hospital Stay Among Patients with Respiratory Failure due to Critical COVID-19
finance.yahoo.com - February 9 at 8:33 AM |
| NeuroRx reports Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™ (aviptadil) in Reducing Hospital Stay among Patients with Respiratory Failure due to Critical COVID-19
finance.yahoo.com - February 9 at 8:33 AM |
| Relief Affirms Initiation of Phase 2/3 Trial of Inhaled RLF-100(TM) (Aviptadil; ZYESAMI(TM)) in Severe COVID-19 Patients
finance.yahoo.com - February 8 at 4:22 AM |
| Relief Therapeutics and Acer ink option agreement for development of ACER-001
seekingalpha.com - January 27 at 12:14 AM |
| Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease
finance.yahoo.com - January 25 at 8:46 AM |
| Relief Therapeutics Holding AG: Relief Announces Implementation of New Share Subscription Facility with Main Shareholder GEM
finanznachrichten.de - January 22 at 6:50 PM |
| Relief Announces Implementation of New Share Subscription Facility with Main Shareholder GEM
finance.yahoo.com - January 21 at 3:29 AM |
| Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil
finance.yahoo.com - January 20 at 3:09 AM |
 | NeuroRx, Relief, Quantum Leap To Include ZYESAMI In I-SPY COVID-19 Trial
nasdaq.com - January 11 at 2:05 AM |
 | EQS-News: Relief and NeuroRx Conclude Enrollment in their Phase 2b/3 Trial of RLF-100(TM) for Critical COVID-19 with Respiratory Failure
marketwatch.com - December 30 at 1:24 PM |
 | News for Relief Therapeutics
markets.businessinsider.com - December 23 at 11:36 PM |
| Relief Appoints Chris L.J.J. Stijnen as Chief Commercial Officer
finance.yahoo.com - December 21 at 8:43 AM |
| Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority
finance.yahoo.com - December 18 at 9:39 AM |
| RELIEF THERAPEUTICS HOLDING AG
finanznachrichten.de - November 27 at 1:20 AM |
| CORRECTION: NeuroRx and Relief Announce Initial Successful Results from Expanded Access Use of RLF-100(TM) (aviptadil) in Patients with Critical COVID-19 and Severe Comorbidity: 72% Survival Seen in ICU Patients
finance.yahoo.com - November 25 at 5:09 PM |
| NeuroRx and Relief announce initial successful results from expanded access use of RLF-100™ (aviptadil) in patients with Critical COVID-19 and Severe Comorbidity: 72% survival seen in ICU patients
finance.yahoo.com - November 24 at 11:04 AM |
| NeuroRx and Relief Announce Initial Successful Results from Expanded Access Use of RLF-100(TM) (Aviptadil) in Patients with Critical COVID-19 and Severe Comorbidity: 72% Survival Seen in ICU Patients
finance.yahoo.com - November 24 at 6:03 AM |
| EQS-News: Relief Announces Notice of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG
marketwatch.com - November 23 at 4:05 AM |
| Relief Announces Notice of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG
finance.yahoo.com - November 23 at 4:05 AM |
| Relief hires research and manufacturing firms in Europe for development of RLF-100
seekingalpha.com - November 18 at 8:59 AM |
| NeuroRx and Relief Therapeutics announce enrollment of 150 patients in phase 2b/3 trial of RLF-100™ for Critical COVID-19 with Respiratory Failure
finance.yahoo.com - November 13 at 10:25 AM |
